IOVA (Iovance Biotherapeutics Inc) Technical Analysis

IOVA Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
IOVA
IOVA

Iovance Biotherapeutics Inc

$4.12-0.24%
Today's High$4.28
Today's Low$4.01
Today's Open$4.15
Yesterday's Close$4.13

IOVA (Iovance Biotherapeutics Inc) Technical Analysis Overview

AI CreationAs of July 1, 2026, Iovance Biotherapeutics Inc (IOVA) is showing bullish momentum. The MACD level of 0.1076 confirms a buy signal with sustained upward momentum, while RSI(14) at 56.87 occupies the neutral-to-strong zone, indicating that buying pressure has maintained equilibrium without yet reaching overbought extremes. The moving average system demonstrates robust bullish alignment, with fourteen buy signals and only one neutral reading across the daily timeframe, suggesting consistent upside structure. The **IOVA technical analysis** remains constructive, though ADX(14) at 21.04 signals weak trend strength, suggesting the advance may face periods of consolidation rather than sustained directional persistence.

Oscillators

Strong Sell
Strong Buy
Neutral
1
Sell
9
Neutral
1
Buy

Summary

Strong Sell
Strong Buy
Buy
5
Sell
10
Neutral
11
Buy

Moving Averages

Strong Sell
Strong Buy
Buy
4
Sell
1
Neutral
10
Buy

IOVA (Iovance Biotherapeutics Inc) Live Candlestick Chart

IOVA (Iovance Biotherapeutics Inc) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)3116810495
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)37.948.151.757.2
MACD (12,26)Death CrossGolden CrossGolden CrossGolden Cross

IOVA (Iovance Biotherapeutics Inc) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
51.7663Neutral
Stochastic %K (14, 3, 3)
43.1293Neutral
Commodity Channel Index (CCI) (20)
-0.6168Neutral
Average Directional Index (ADX) (14)
21.2126Neutral
Awesome Oscillator (AO)
0.2359Neutral
Momentum Indicator (10)
0.2797Buy
MACD Level (12, 26)
0.0867Sell
Stochastic RSI Fast (3, 3, 14, 14)
41.7263Neutral
Williams Percent Range (%R) (14)
-62.2426Neutral
Bull Bear Power (BBP)
-0.0455Neutral
Ultimate Oscillator (UO) (7, 14, 28)
39.0136Neutral

Moving Averages

NameValueOperation
EMA (10)
4.1432Sell
SMA (10)
4.152Sell
EMA (20)
4.0813Buy
SMA (20)
4.0735Buy
EMA (30)
4.0216Buy
SMA (30)
4.0403Buy
EMA (50)
3.9154Buy
SMA (50)
3.8522Buy
EMA (100)
3.666Buy
SMA (100)
3.7355Buy
EMA (200)
3.4983Buy
SMA (200)
3.0434Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
4.2293Neutral
Volume-Weighted Moving Average (VWMA) (20)
4.1081Sell
Hull Moving Average (HMA) (9)
4.1678Sell

IOVA (Iovance Biotherapeutics Inc) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R36.42335.19334.43835.955-
R25.19334.72354.32555.2325-
R14.64674.43324.21284.7254.92
Pivot P3.96333.96333.96334.00254.1
S13.41673.49353.98723.4953.69
S22.73333.20323.87452.7725-
S31.50332.73333.76172.265-

IOVA (Iovance Biotherapeutics Inc) Market Sentiment Index

Analyst Rating8.8
Options Put/Call Ratio+6.31%
Implied Volatility (IV)4.5201

IOVA (Iovance Biotherapeutics Inc) Deep Technical Analysis

As of July 1, 2026, IOVA is exhibiting a bullish technical structure. The MACD level stands at 0.1076 with a buy signal, reflecting positive momentum continuation, while RSI(14) at 56.87 occupies the neutral-to-strong zone, indicating that buying pressure has maintained equilibrium with room for further upside without yet reaching overbought extremes. This **IOVA price outlook** reflects sustained buying interest across the daily timeframe. ADX(14) measures 21.04, signaling a weak trend structure that suggests the current advance, while directionally bullish, lacks the persistence needed to avoid consolidation phases. The Commodity Channel Index at 66.51 registers a neutral signal, indicating that price extremes relative to the moving average have stabilized, and the Momentum(10) value of 0.265 with a buy signal confirms alignment with the overall bullish picture, implying that momentum remains supported even as the trend strengthens. The moving average system demonstrates strong bullish configuration with EMA10 at 4.1774 and EMA20 at 4.0922 trading above the medium-term EMA50 at 3.9132, establishing a bullish hierarchy in the short term. The SMA20 at 4.0803 aligns above the longer-period SMA200 at 3.0349, confirming that price remains well above its two-hundred-day baseline and supporting a longer-term uptrend structure. This layered bullish arrangement in the **IOVA market analysis** suggests that intermediate-term support remains intact and positioned to sustain any pullbacks toward the EMA50 level. In terms of key levels, Fibonacci retracement points establish resistance targets at 4.4332 (R1), 4.7235 (R2), and 5.1933 (R3), while support levels are positioned at 3.4935 (S1), 3.2032 (S2), and 2.7333 (S3). The current price of 4.20 sits below the first resistance level, indicating that the near-term **IOVA price forecast** may encounter profit-taking or consolidation around the 4.4332 level before attempting a fresh advance. The daily range of 4.13 to 4.31 reflects moderate volatility, and the Camarilla pivot system suggests the 3.9872 level serves as immediate support. On the sentiment front, the analyst rating of 8.8 out of ten reflects overall positive conviction among research professionals, supporting the technical bullish case. The put-call ratio of 6.31 indicates elevated hedging activity, which may reflect some defensive positioning despite the bullish price structure, suggesting that while upside momentum is intact, market participants are maintaining protective strategies. This mixed sentiment backdrop implies that the **IOVA price prediction** remains constructive on structure but tempered by cautious positioning in options markets.

FAQ

What is the current technical rating for IOVA?

x
On the 4H timeframe, the aggregate technical rating for IOVA is Buy. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for IOVA?

x

What are the current RSI and MACD signals for IOVA?

x

How often is the IOVA technical analysis data updated?

x

Continue Exploring IOVA (Iovance Biotherapeutics Inc)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.